EX-23.1 53 d755217dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated June 26, 2019 in the Registration Statement (Form S-1) and related Prospectus of Vir Biotechnology, Inc. for the registration of shares of its common stock.

 

/s/ Ernst & Young LLP

Redwood City, California

September 3, 2019